Hong Kong stock anomaly | Luoppu Biological-B (02157.HK) rises over 8% again, CG Oncology oncolytic virus therapy phase III trial data looks promising.

According to the Securities Times app, Luoyue Bioscience-B (02157.HK) surged over 8% again, as of the time of publication, up 7.17% to 4.93 Hong Kong dollars, with a turnover of 39.0279 million Hong Kong dollars.